Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review
In addition to evaluating disease activity with clinician-reported measures, the field could obtain critical knowledge on the patient experience by including high-quality PROMs of symptoms and functioning. More clinical trials using a variety of outcomes and measures are necessary to determine the most suitable course of treatment for LS patients.
Authors
- Alexy Hernandez (ORCID: https://orcid.org/0000-0002-6474-3001)
- Leila Ledbetter (ORCID: https://orcid.org/0000-0002-5206-8002)
- Kathryn S. Torok (ORCID: https://orcid.org/0000-0002-1662-143X)
- Christina K. Zigler (ORCID: https://orcid.org/0000-0002-8996-7757)
- Leslie Zapata Leiva
- Maria Mutka
Institutions
- University of Pittsburgh (US)
- Duke University (US)
- RTI International (US)
- Smith College (US)
- Children's Hospital of Pittsburgh (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Pediatric Rheumatology
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1186/s12969-024-01014-x
- Citations
- 3
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.27